Omar Motiño

Nov 15, 2024 | nature.com | Omar Motiño |Gerasimos Anagnostopoulos |Léa Montégut |Hui Chen |Maria Chiara Maiuri |Federico Pietrocola | +1 more

AbstractAcyl-CoA binding protein (ACBP), also known as diazepam-binding inhibitor (DBI), is an extracellular checkpoint of autophagy. Here, we report that patients with histologically confirmed metabolic-associated steatohepatitis (MASH) or liver fibrosis exhibit elevated levels of circulating ACBP/DBI protein as compared to non-affected controls. Plasma ACBP/DBI strongly correlated with the NAFLD and FIB4 scores in patients, and these correlations were independent of age and body mass index.